Skip to main content

Table 4 Distribution of the patients (%) with active or inactive Crohn’s disease according to the drugs that were taken before and during the study

From: A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study

Drug Before the study G1 During the study G1
Active CD Inactive CD Active CD Inactive CD
n (%) n (%) n (%) n (%)
(Group I) (Group II) (Group I) (Group II)
Azathioprine 22(100) 25(86.2) NS 21(95.4) 18(62.1) *
Sulfasalazine 3(13.6) 3(10.3) NS 2(9.1) 1(3.5) NS
Mesalazine 20(90.9) 15(51.7) * 10(45.4) 16(55.2) NS
Ciprofloxacin 12(54.5) 16(55.2) NS 3(13.6) 12(41) *
Metronidazole 10(45.4) 11(37.9) NS 4(18.2) 2(6.9) NS
Infliximab 8(36.3) 6(20.7) NS 5(23.1) 5(17.2) NS
  1. CD Crohn’s disease, G1 group I vs. group II, NS not significant; *p < 0.05